Immune system disturbances in schizophrenia

Szatmár Horváth, Karoly Mirnics

Research output: Contribution to journalReview article

80 Citations (Scopus)

Abstract

Epidemiological, genetic, transcriptome, postmortem, peripheral biomarker, and therapeutic studies of schizophrenia all point to a dysregulation of both innate and adaptive immune systems in the disease, and it is likely that these immune changes actively contribute to disease symptoms. Gene expression disturbances in the brain of subjects with schizophrenia show complex, region-specific changes with consistently replicated and potentially interdependent induction of serpin peptidase inhibitor, clade A member 3 (SERPINA3) and interferon inducible transmembrane protein (IFITM) family transcripts in the prefrontal cortex. Recent data suggest that IFITM3 expression is a critical mediator of maternal immune activation. Because the IFITM gene family is primarily expressed in the endothelial cells and meninges, and because the meninges play a critical role in interneuron development, we suggest that these two non-neuronal cell populations might play an important role in the disease pathophysiology. Finally, we propose that IFITM3 in particular might be a novel, appealing, knowledge-based drug target for treatment of schizophrenia.

Original languageEnglish (US)
Pages (from-to)316-323
Number of pages8
JournalBiological Psychiatry
Volume75
Issue number4
DOIs
StatePublished - Feb 15 2014

Fingerprint

Meninges
Immune System
Schizophrenia
Interferons
Serpins
Immune System Diseases
Interneurons
Protease Inhibitors
Prefrontal Cortex
Transcriptome
Proteins
Endothelial Cells
Biomarkers
Mothers
Gene Expression
Brain
Pharmaceutical Preparations
Population
Therapeutics

Keywords

  • Blood-brain barrier
  • CD14
  • CHI3L1
  • IFITM
  • IFITM3
  • SERPINA3
  • blood vessels
  • immune
  • meninges
  • pia mater
  • postmortem
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Immune system disturbances in schizophrenia. / Horváth, Szatmár; Mirnics, Karoly.

In: Biological Psychiatry, Vol. 75, No. 4, 15.02.2014, p. 316-323.

Research output: Contribution to journalReview article

Horváth, Szatmár ; Mirnics, Karoly. / Immune system disturbances in schizophrenia. In: Biological Psychiatry. 2014 ; Vol. 75, No. 4. pp. 316-323.
@article{772f65c7ef194d94b2542694a07d80b9,
title = "Immune system disturbances in schizophrenia",
abstract = "Epidemiological, genetic, transcriptome, postmortem, peripheral biomarker, and therapeutic studies of schizophrenia all point to a dysregulation of both innate and adaptive immune systems in the disease, and it is likely that these immune changes actively contribute to disease symptoms. Gene expression disturbances in the brain of subjects with schizophrenia show complex, region-specific changes with consistently replicated and potentially interdependent induction of serpin peptidase inhibitor, clade A member 3 (SERPINA3) and interferon inducible transmembrane protein (IFITM) family transcripts in the prefrontal cortex. Recent data suggest that IFITM3 expression is a critical mediator of maternal immune activation. Because the IFITM gene family is primarily expressed in the endothelial cells and meninges, and because the meninges play a critical role in interneuron development, we suggest that these two non-neuronal cell populations might play an important role in the disease pathophysiology. Finally, we propose that IFITM3 in particular might be a novel, appealing, knowledge-based drug target for treatment of schizophrenia.",
keywords = "Blood-brain barrier, CD14, CHI3L1, IFITM, IFITM3, SERPINA3, blood vessels, immune, meninges, pia mater, postmortem, schizophrenia",
author = "Szatm{\'a}r Horv{\'a}th and Karoly Mirnics",
year = "2014",
month = "2",
day = "15",
doi = "10.1016/j.biopsych.2013.06.010",
language = "English (US)",
volume = "75",
pages = "316--323",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Immune system disturbances in schizophrenia

AU - Horváth, Szatmár

AU - Mirnics, Karoly

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Epidemiological, genetic, transcriptome, postmortem, peripheral biomarker, and therapeutic studies of schizophrenia all point to a dysregulation of both innate and adaptive immune systems in the disease, and it is likely that these immune changes actively contribute to disease symptoms. Gene expression disturbances in the brain of subjects with schizophrenia show complex, region-specific changes with consistently replicated and potentially interdependent induction of serpin peptidase inhibitor, clade A member 3 (SERPINA3) and interferon inducible transmembrane protein (IFITM) family transcripts in the prefrontal cortex. Recent data suggest that IFITM3 expression is a critical mediator of maternal immune activation. Because the IFITM gene family is primarily expressed in the endothelial cells and meninges, and because the meninges play a critical role in interneuron development, we suggest that these two non-neuronal cell populations might play an important role in the disease pathophysiology. Finally, we propose that IFITM3 in particular might be a novel, appealing, knowledge-based drug target for treatment of schizophrenia.

AB - Epidemiological, genetic, transcriptome, postmortem, peripheral biomarker, and therapeutic studies of schizophrenia all point to a dysregulation of both innate and adaptive immune systems in the disease, and it is likely that these immune changes actively contribute to disease symptoms. Gene expression disturbances in the brain of subjects with schizophrenia show complex, region-specific changes with consistently replicated and potentially interdependent induction of serpin peptidase inhibitor, clade A member 3 (SERPINA3) and interferon inducible transmembrane protein (IFITM) family transcripts in the prefrontal cortex. Recent data suggest that IFITM3 expression is a critical mediator of maternal immune activation. Because the IFITM gene family is primarily expressed in the endothelial cells and meninges, and because the meninges play a critical role in interneuron development, we suggest that these two non-neuronal cell populations might play an important role in the disease pathophysiology. Finally, we propose that IFITM3 in particular might be a novel, appealing, knowledge-based drug target for treatment of schizophrenia.

KW - Blood-brain barrier

KW - CD14

KW - CHI3L1

KW - IFITM

KW - IFITM3

KW - SERPINA3

KW - blood vessels

KW - immune

KW - meninges

KW - pia mater

KW - postmortem

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84892572641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892572641&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2013.06.010

DO - 10.1016/j.biopsych.2013.06.010

M3 - Review article

VL - 75

SP - 316

EP - 323

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 4

ER -